IFNA1 and COVID-19: The molecular mechanism(s) of this IFN evasion remain to be confirmed, however, several studies have suggested different pathways that could contribute to the decreased amount of IFNs in severe COVID-19 patients, from concealed viral production invisible to PPARs to direct synthesis of structural and nonstructural viral proteins that antagonize IFN signaling (47–49).